The Pharmacological Characterization of 5-HT3 Receptors in Three Isolated Preparations Derived from Guinea-pig Tissues

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1990 Nov 1

PMID 2076479

Citations 28

Authors

A Butler

C J Elswood

J Burridge

S J Ireland

K T Bunce

G J Kilpatrick

M B Tyers

Affiliations

Soon will be listed here.

Abstract

1. The pharmacological characterization of the 5-HT3 receptors in guinea-pig isolated tissues is described. The tissues used were ileum (longitudinal muscle-myenteric plexus), colon and vagus nerve. The guinea-pig isolated colon is a novel preparation. 2. In the guinea-pig isolated ileum, 5-hydroxytryptamine (5-HT, 1 x 10(-8)-3 x 10(-5) M) and the selective 5-HT3 receptor agonist 2-methyl-5-HT (3 x 10(-7)-1 x 10(-4) M) caused concentration-related contractions. The 5-HT concentration-response curve was biphasic whilst the 2-methyl-5-HT curve was monophasic. The EC50 value for the low potency portion of the 5-HT curve was 4.1 x 10(-6) M. The EC50 for 2-methyl-5-HT was 1.23 x 10(-5) M. Selective 5-HT3 receptor antagonists caused rightward shifts of the 2-methyl-5-HT curve and the lower potency portion of the 5-HT curve. Neither ketanserin (1 x 10(-6) M) nor methysergide (1 x 10(-5) M) antagonized the responses to 5-HT or 2-methyl-5-HT. 3. In the guinea-pig isolated colon, 5-HT (3 x 10(-7)-3 x 10(-5) M; EC50 2.4 x 10(-6) M) caused contractions which were mimicked by 2-methyl-5-HT (1 x 10(-6)-1 x 10(-4) M; EC50 7.2 x 10(-6) M). Selective 5-HT3 receptor antagonists caused rightward displacements of the 5-HT concentration-response curves. Neither ketanserin (1 x 10-6 M) nor methysergide (1 x 10- 5M) had any effect on responses to 5-HT or 2-methyl- 5-HT. 4. In the guinea-pig isolated vagus nerve, 5-HT (1 x 10-6-3 x 1O-4M) and 2-methyl-5-HT (1 x i0-S- 1 X 10-3m; EC50 7.6 x 10- M) caused depolarizations; at higher concentrations there were afterhyperpolarizations. The maximum response to 2-methyl-5-HT was less than half that to 5-HT. Selective 5-HT3 receptor antagonists caused rightward displacements of the 5-HT concentration-response curves. Antagonists at other 5-HT receptors (ketanserin, 1 x 10- M and methysergide, 1 x 10-6 M) had no effect. 5. The estimated affinity values of 5-HT3 receptor antagonists correlated well between the three models. Phenylbiguanide was inactive as an agonist or antagonist (up to 1 x 1O-4M) in each preparation. 6. Comparisons with antagonist affinity values obtained in the rat isolated vagus nerve revealed marked differences. Antagonists were generally more potent on the rat isolated vagus nerve, although the differences varied considerably between antagonists. 7. The results are discussed in terms of species-related receptor differences.

Citing Articles

5-HT3 receptors.

Thompson A, Lummis S Curr Pharm Des. 2006; 12(28):3615-30.

PMID: 17073663 PMC: 2664614. DOI: 10.2174/138161206778522029.

Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve.

Kagaya M, Lamb J, Robbins J, Page C, Spina D Br J Pharmacol. 2002; 137(1):39-48.

PMID: 12183329 PMC: 1573467. DOI: 10.1038/sj.bjp.0704840.

The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.

Yoshikawa T, Yoshida N, Oka M Br J Pharmacol. 2001; 133(2):253-60.

PMID: 11350861 PMC: 1572785. DOI: 10.1038/sj.bjp.0704078.

Pharmacological characterization of the 5-HT receptor-mediated contraction in the mouse isolated ileum.

Tuladhar B, Womack M, Naylor R Br J Pharmacol. 2001; 131(8):1716-22.

PMID: 11139451 PMC: 1572506. DOI: 10.1038/sj.bjp.0703747.

Characterization of the 5-hydroxytryptamine receptors mediating contraction in the intestine of Suncus murinus.

Javid F, Naylor R Br J Pharmacol. 1999; 127(8):1867-75.

PMID: 10482918 PMC: 1566174. DOI: 10.1038/sj.bjp.0702729.

References

Kilpatrick G, Jones B, Tyers M . Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur J Pharmacol. 1989; 159(2):157-64. DOI: 10.1016/0014-2999(89)90700-0. View

Sanger G, Nelson D . Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron). Eur J Pharmacol. 1989; 159(2):113-24. DOI: 10.1016/0014-2999(89)90695-x. View

Derkach V, Surprenant A, North R . 5-HT3 receptors are membrane ion channels. Nature. 1989; 339(6227):706-9. DOI: 10.1038/339706a0. View

Kilpatrick G, Butler A, Burridge J, Oxford A . 1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist. Eur J Pharmacol. 1990; 182(1):193-7. DOI: 10.1016/0014-2999(90)90513-6. View

Kilpatrick G, Butler A, Hagan R, Jones B, Tyers M . [3H] GR67330, a very high affinity ligand for 5-HT3 receptors. Naunyn Schmiedebergs Arch Pharmacol. 1990; 342(1):22-30. DOI: 10.1007/BF00178967. View

Gaddum J, PICARELLI Z . Two kinds of tryptamine receptor. Br J Pharmacol Chemother. 1957; 12(3):323-8. PMC: 1509685. DOI: 10.1111/j.1476-5381.1957.tb00142.x. View

ARUNLAKSHANA O, SCHILD H . Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959; 14(1):48-58. PMC: 1481829. DOI: 10.1111/j.1476-5381.1959.tb00928.x. View

FASTIER F, McDowall M, Waal H . Pharmacological properties of phenyldiguanide and other amidine derivatives in relation to those of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1959; 14:527-35. PMC: 1481901. DOI: 10.1111/j.1476-5381.1959.tb00960.x. View

Paton W, WAUD D . The margin of safety of neuromuscular transmission. J Physiol. 1967; 191(1):59-90. PMC: 1365439. DOI: 10.1113/jphysiol.1967.sp008237. View

10.

Wallis D, Nash H . Relative activities of substances related to 5-hydroxytryptamine as depolarizing agents of superior cervical ganglion cells. Eur J Pharmacol. 1981; 70(3):381-92. DOI: 10.1016/0014-2999(81)90171-0. View

11.

Higashi H, Nishi S . 5-Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia. J Physiol. 1982; 323:543-67. PMC: 1250375. DOI: 10.1113/jphysiol.1982.sp014091. View

12.

Fozard J . MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1984; 326(1):36-44. DOI: 10.1007/BF00518776. View

13.

Kenakin T . The classification of drugs and drug receptors in isolated tissues. Pharmacol Rev. 1984; 36(3):165-222. View

14.

Buchheit K, Engel G, Mutschler E, Richardson B . Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Evidence for two distinct release mechanisms. Naunyn Schmiedebergs Arch Pharmacol. 1985; 329(1):36-41. DOI: 10.1007/BF00695189. View

15.

Richardson B, Engel G, Donatsch P, Stadler P . Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 1985; 316(6024):126-31. DOI: 10.1038/316126a0. View

16.

Bradley P, Engel G, Feniuk W, Fozard J, Humphrey P, Middlemiss D . Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 1986; 25(6):563-76. DOI: 10.1016/0028-3908(86)90207-8. View

17.

Ireland S, Straughan D, Tyers M . Influence of 5-hydroxytryptamine uptake on the apparent 5-hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglion. Br J Pharmacol. 1987; 90(1):151-60. PMC: 1917299. DOI: 10.1111/j.1476-5381.1987.tb16835.x. View

18.

Ireland S, Tyers M . Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br J Pharmacol. 1987; 90(1):229-38. PMC: 1917290. DOI: 10.1111/j.1476-5381.1987.tb16844.x. View

19.

Ireland S . Origin of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion and vagus nerve. Br J Pharmacol. 1987; 92(2):407-16. PMC: 1853653. DOI: 10.1111/j.1476-5381.1987.tb11337.x. View

20.

Kilpatrick G, Jones B, Tyers M . Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature. 1987; 330(6150):746-8. DOI: 10.1038/330746a0. View